These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23324623)

  • 1. Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.
    Madhavi V; Navis M; Chung AW; Isitman G; Wren LH; De Rose R; Kent SJ; Stratov I
    Hum Vaccin Immunother; 2013 May; 9(5):1011-8. PubMed ID: 23324623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid degranulation of NK cells following activation by HIV-specific antibodies.
    Chung AW; Rollman E; Center RJ; Kent SJ; Stratov I
    J Immunol; 2009 Jan; 182(2):1202-10. PubMed ID: 19124764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection.
    Chen X; Lin M; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Dong T; Shang H; Jiang Y
    Front Immunol; 2018; 9():2322. PubMed ID: 30356637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.
    Fisher L; Zinter M; Stanfield-Oakley S; Carpp LN; Edwards RW; Denny T; Moodie Z; Laher F; Bekker LG; McElrath MJ; Gilbert PB; Corey L; Tomaras G; Pollara J; Ferrari G
    Front Immunol; 2019; 10():2741. PubMed ID: 31827470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.
    Lee WS; Richard J; Lichtfuss M; Smith AB; Park J; Courter JR; Melillo BN; Sodroski JG; Kaufmann DE; Finzi A; Parsons MS; Kent SJ
    J Virol; 2016 Feb; 90(4):2021-30. PubMed ID: 26656700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
    J Virol; 2019 May; 93(10):. PubMed ID: 30842324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.
    Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; ; Stratov I; Navis M; Kent SJ
    Immunology; 2013 Feb; 138(2):116-23. PubMed ID: 23173935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
    Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
    J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.
    Wren L; Parsons MS; Isitman G; Center RJ; Kelleher AD; Stratov I; Bernard NF; Kent SJ
    PLoS One; 2012; 7(6):e38580. PubMed ID: 22701674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient IL-2 Produced by Activated CD56
    Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
    Front Immunol; 2019; 10():1647. PubMed ID: 31379845
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of NK cells by ADCC responses during early HIV infection.
    Chung AW; Navis M; Isitman G; Centre R; Finlayson R; Bloch M; Gelgor L; Kelleher A; Kent SJ; Stratov I
    Viral Immunol; 2011 Apr; 24(2):171-5. PubMed ID: 21449728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
    Ahmad A; Menezes J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive investigation of common antibody-dependent cell-mediated cytotoxicity antibody epitopes of HIV-1 CRF01_AE gp120.
    Ampol S; Pattanapanyasat K; Sutthent R; Permpikul P; Kantakamalakul W
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1250-8. PubMed ID: 22288892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.
    Liu Q; Sun Y; Rihn S; Nolting A; Tsoukas PN; Jost S; Cohen K; Walker B; Alter G
    J Virol; 2009 Sep; 83(17):8705-12. PubMed ID: 19553339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
    Jensen SS; Fomsgaard A; Borggren M; Tingstedt JL; Gerstoft J; Kronborg G; Rasmussen LD; Pedersen C; Karlsson I
    PLoS One; 2015; 10(12):e0145249. PubMed ID: 26696395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
    Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
    EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells.
    Gooneratne SL; Richard J; Lee WS; Finzi A; Kent SJ; Parsons MS
    J Virol; 2015 Jan; 89(1):97-109. PubMed ID: 25320293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.